Terms: = Bone cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
1051 results:
1. Investigating the molecular mechanism of Mori Cortex against osteosarcoma by bioinformatics analysis and in vitro experimental.
Wang Y; Wang L; Xie D; Chen B
Medicine (Baltimore); 2024 May; 103(20):e38261. PubMed ID: 38758844
[TBL] [Abstract] [Full Text] [Related]
2. TNF-α can promote membrane invasion by activating the MAPK/MMP9 signaling pathway through autocrine in bone-invasive pituitary adenoma.
Wu X; Gong L; Li B; Bai J; Li C; Zhang Y; Zhu H
CNS Neurosci Ther; 2024 May; 30(5):e14749. PubMed ID: 38739004
[TBL] [Abstract] [Full Text] [Related]
3. KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway.
Zhai M; Miao J; Zhang R; Liu R; Li F; Shen Y; Wang T; Xu X; Gao G; Hu J; He A; Bai J
J Cancer Res Clin Oncol; 2024 May; 150(5):239. PubMed ID: 38713252
[TBL] [Abstract] [Full Text] [Related]
4. Favorable impact of PD1/PD-L1 antagonists on bone remodeling: an exploratory prospective clinical study and ex vivo validation.
Gassner T; Chittilappilly C; Pirich T; Neuditschko B; Hackner K; Lind J; Aksoy O; Graichen U; Klee S; Herzog F; Wiesner C; Errhalt P; Pecherstorfer M; Podar K; Vallet S
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38702145
[TBL] [Abstract] [Full Text] [Related]
5. ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/erk pathway.
Zheng D; Wei Z; Zhang C; Liu W; Gong C; Wu F; Guo W
Biol Direct; 2024 Apr; 19(1):28. PubMed ID: 38650011
[TBL] [Abstract] [Full Text] [Related]
6. IFNα-induced BST2
Zheng C; Wang J; Zhou Y; Duan Y; Zheng R; Xie Y; Wei X; Wu J; Shen H; Ye M; Kong B; Liu Y; Xu P; Zhang Q; Liang T
Cell Rep; 2024 Apr; 43(4):114088. PubMed ID: 38602878
[TBL] [Abstract] [Full Text] [Related]
7. miR-889-3p targeting BMPR2 promotes the development of retinoblastoma via JNK/MAPK/erk signaling.
Gao Y; Du P
Sci Rep; 2024 Mar; 14(1):7277. PubMed ID: 38538669
[TBL] [Abstract] [Full Text] [Related]
8. Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells.
Li M; Zhang CL; Zhou DS; Chan SH; Liu XQ; Chen SN; Yang ZY; Ju FE; Sang XY; Liu ZX; Zhang QX; Pan YM; Deng SS; Wang XM; Zhong L; Zhang XD; Du X
Br J Haematol; 2024 Apr; 204(4):1307-1324. PubMed ID: 38462771
[TBL] [Abstract] [Full Text] [Related]
9. Esketamine inhibits the c-Jun N-terminal kinase pathway in the spinal dorsal horn to relieve bone cancer pain in rats.
Duan C; Zhu Y; Zhang Z; Wu T; Shen M; Xu J; Gao W; Pan J; Wei L; Su H; Shi C
Mol Pain; 2024; 20():17448069241239231. PubMed ID: 38417838
[TBL] [Abstract] [Full Text] [Related]
10. Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma.
Rooper LM; Agaimy A; Bell D; Gagan J; Gallia GL; Jo VY; Lewis JS; London NR; Nishino M; Stoehr R; Thompson LDR; Din NU; Wenig BM; Westra WH; Bishop JA
Mod Pathol; 2024 May; 37(5):100448. PubMed ID: 38369189
[TBL] [Abstract] [Full Text] [Related]
11. Revealing the pharmacological effects of Remodelin against osteosarcoma based on network pharmacology, acRIP-seq and experimental validation.
Gao J; Xu P; Wang F; Zhang W; Min M; Urba R; Fan L
Sci Rep; 2024 Feb; 14(1):3577. PubMed ID: 38347067
[TBL] [Abstract] [Full Text] [Related]
12. Dipsacus Asperoides-Derived Exosomes-Like Nanoparticles Inhibit the Progression of Osteosarcoma via Activating p38/JNK Signaling Pathway.
Lu J; Chen J; Ye J; Shi Z; Gao X; Chen P; Chang Y; Lin H; Li P
Int J Nanomedicine; 2024; 19():1097-1108. PubMed ID: 38327597
[TBL] [Abstract] [Full Text] [Related]
13. Periostin in cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing cancer and Stromal Cell Migration.
Miyako S; Koma YI; Nakanishi T; Tsukamoto S; Yamanaka K; Ishihara N; Azumi Y; Urakami S; Shimizu M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Am J Pathol; 2024 May; 194(5):828-848. PubMed ID: 38320632
[TBL] [Abstract] [Full Text] [Related]
14. A plasma membrane-associated form of the androgen receptor enhances nuclear androgen signaling in osteoblasts and prostate cancer cells.
Kalyanaraman H; Casteel DE; China SP; Zhuang S; Boss GR; Pilz RB
Sci Signal; 2024 Jan; 17(821):eadi7861. PubMed ID: 38289986
[TBL] [Abstract] [Full Text] [Related]
15. Nε-(1-Carboxymethyl)-L-lysine/RAGE Signaling Drives Metastasis and cancer Stemness through erk/NFκB axis in Osteosarcoma.
Chang TY; Lan KC; Wu CH; Sheu ML; Yang RS; Liu SH
Int J Biol Sci; 2024; 20(3):880-896. PubMed ID: 38250151
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical pathological and genetic mutation characteristics of conjunctival lymphoepithelial carcinoma].
Wang YC; Li J; Guo YT; Li J; Lin JY
Zhonghua Yan Ke Za Zhi; 2024 Jan; 60(1):64-71. PubMed ID: 38199770
[No Abstract] [Full Text] [Related]
17. Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and
Pang H; Wu H; Zhan Z; Wu T; Xiang M; Wang Z; Song L; Wei B
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186298
[TBL] [Abstract] [Full Text] [Related]
18. Activation of HDAC8 Can Suppress the Proliferation of Osteosarcoma Cells via
Wang L; Bai X; Zhang X; Wang X; Chen S; Wu S; Lin L
Ann Clin Lab Sci; 2023 Nov; 53(6):920-930. PubMed ID: 38182151
[TBL] [Abstract] [Full Text] [Related]
19. bone morphogenetic protein-9 downregulates StAR expression by inducing snail expression via SMAD1/5/8 signaling in human granulosa-lutein cells.
Liu B; Fu B; Zhou S; Wang H; Bi B; Guo M; Cheng JC; Fang L
Mol Cell Endocrinol; 2024 Mar; 582():112126. PubMed ID: 38109991
[TBL] [Abstract] [Full Text] [Related]
20. Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking.
Liu MY; Jiang DX; Zhao X; Zhang L; Zhang Y; Liu ZD; Liu RZ; Li HJ; Rong XY; Gao YZ
Orthop Surg; 2024 Feb; 16(2):462-470. PubMed ID: 38086608
[TBL] [Abstract] [Full Text] [Related]
[Next]
